Sigma Planning’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
Sigma Planning's XPH Position: Q3 2026 in Review
Sigma Planning reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 3.3% in Q3 2026, selling an estimated $13.8K and leaving 5,889 shares worth $379K. The position accounts for 0.01% of the portfolio, ranked #962.
Sigma Planning first reported a position in XPH in Q4 2016 and has held it in 9 quarters since. The position peaked at $403K in Q2 2026. 96 funds tracked by Wall St. Rank hold XPH as of Q3 2026.
- Sigma Planning held 5,889 shares of State Street SPDR S&P Pharmaceuticals ETF worth $379K as of Q3 2026.
- Sigma Planning sold 199 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2026, an estimated $13.8K.
- State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #962 holding.
- Sigma Planning first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and has held it in 9 quarters since.
- Sigma Planning's State Street SPDR S&P Pharmaceuticals ETF position peaked at $403K in Q2 2026.
- 96 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.